SMS Lifesciences India Limited

NSEI:SMSLIFE 주식 보고서

시가총액: ₹4.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SMS Lifesciences India 대차 대조표 상태

재무 상태 기준 확인 3/6

SMS Lifesciences India 의 총 주주 지분은 ₹1.9B 이고 총 부채는 ₹977.1M, 이는 부채 대 자기자본 비율을 50.5% 로 가져옵니다. 총자산과 총부채는 각각 ₹3.9B 및 ₹2.0B 입니다. SMS Lifesciences India 의 EBIT는 ₹161.8M 이며 이자보상배율은 1.6 입니다. ₹14.9M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

52.0%

부채 비율

₹1.01b

부채

이자 보상 비율2.9x
현금₹14.93m
주식₹1.94b
총 부채₹1.97b
총 자산₹3.91b

최근 재무 상태 업데이트

Recent updates

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Aug 01
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Jun 13
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

Feb 10
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Jan 05
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

Sep 23
Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

Sep 07
SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

Aug 24
SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 16
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 02
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

Jun 03
SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

May 13
With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Nov 23
SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Jun 21
Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Feb 22
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 04
SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Nov 27
Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Nov 24
Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

재무 상태 분석

단기부채: SMSLIFE 의 단기 자산 ( ₹1.6B )이 단기 부채( ₹1.4B ).

장기 부채: SMSLIFE 의 단기 자산( ₹1.6B )이 장기 부채( ₹523.2M ).


부채 대 자본 내역 및 분석

부채 수준: SMSLIFE 의 순부채 대 자기자본 비율( 49.7% )은 높음으로 간주됩니다.

부채 감소: SMSLIFE 의 부채 대 자기자본 비율은 지난 5년간 43.9% 에서 50.5% 로 증가했습니다.

부채 범위: SMSLIFE 의 부채는 영업 현금 흐름 ( 24.9% )에 의해 잘 충당되었습니다.

이자 보장: SMSLIFE 의 부채에 대한 이자 지급EBIT( 1.6 x 적용 범위)만큼 잘 덮이지 않음입니다.


대차 대조표


건강한 기업 발견하기